Warning: The NCBI web site requires JavaScript to function. more...
Reduced hepatic insulin extraction in response to gastric inhibitory polypeptide compensates for reduced insulin secretion in normal-weight and normal glucose tolerant first-degree relatives of type 2 diabetic patients.
Rudovich NN, Rochlitz HJ, Pfeiffer AF.
Diabetes. 2004 Sep;53(9):2359-65.PMID: 15331546 [PubMed - indexed for MEDLINE]Related articlesFree article
Similar insulin secretory response to a gastric inhibitory polypeptide bolus injection at euglycemia in first-degree relatives of patients with type 2 diabetes and control subjects.
Meier JJ, Nauck MA, Siepmann N, Greulich M, Holst JJ, Deacon CF, Schmidt WE, Gallwitz B.
Metabolism. 2003 Dec;52(12):1579-85.PMID: 14669159 [PubMed - indexed for MEDLINE]Related articles
The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin.
Meneilly GS, Ryan AS, Minaker KL, Elahi D.
J Clin Endocrinol Metab. 1998 Aug;83(8):2925-32.PMID: 9709971 [PubMed - indexed for MEDLINE]Related articlesFree article
Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests.
van Haeften TW, Dubbeldam S, Zonderland ML, Erkelens DW.
Diabetes Care. 1998 Feb;21(2):278-82.PMID: 9539996 [PubMed - indexed for MEDLINE]Related articlesFree article
Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
Meier JJ, Gallwitz B, Askenas M, Vollmer K, Deacon CF, Holst JJ, Schmidt WE, Nauck MA.
Diabetologia. 2005 Sep;48(9):1872-81. Epub 2005 Jul 12.PMID: 16010522 [PubMed - indexed for MEDLINE]Related articles
The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
Vilsbøll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, Hansen T, Pedersen O, Holst JJ.
J Clin Endocrinol Metab. 2003 Oct;88(10):4897-903.PMID: 14557471 [PubMed - indexed for MEDLINE]Related articlesFree article
Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
Nauck MA, El-Ouaghlidi A, Gabrys B, Hücking K, Holst JJ, Deacon CF, Gallwitz B, Schmidt WE, Meier JJ.
Regul Pept. 2004 Nov 15;122(3):209-17.PMID: 15491793 [PubMed - indexed for MEDLINE]Related articles
Disruption of circadian insulin secretion is associated with reduced glucose uptake in first-degree relatives of patients with type 2 diabetes.
Boden G, Chen X, Polansky M.
Diabetes. 1999 Nov;48(11):2182-8.PMID: 10535452 [PubMed - indexed for MEDLINE]Related articlesFree article
Ghrelin is not suppressed in hyperglycemic clamps by gastric inhibitory polypeptide and arginine.
Rudovich NN, Dick D, Moehlig M, Otto B, Spranger J, Rochlitz HJ, Ristow M, Tschoep M, Pfeiffer AF.
Regul Pept. 2005 Apr 15;127(1-3):95-9.PMID: 15680475 [PubMed - indexed for MEDLINE]Related articles
Stimulation of insulin secretion by intravenous bolus injection and continuous infusion of gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjects.
Meier JJ, Gallwitz B, Kask B, Deacon CF, Holst JJ, Schmidt WE, Nauck MA.
Diabetes. 2004 Dec;53 Suppl 3:S220-4.PMID: 15561915 [PubMed - indexed for MEDLINE]Related articlesFree article
Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight.
Volk A, Renn W, Overkamp D, Mehnert B, Maerker E, Jacob S, Balletshofer B, Häring HU, Rett K.
Exp Clin Endocrinol Diabetes. 1999;107(2):140-7.PMID: 10320055 [PubMed - indexed for MEDLINE]Related articles
Insulin secretion, insulin sensitivity, and hepatic insulin extraction in first-degree relatives of type 2 diabetic patients.
Pimenta WP, Santos ML, Cruz NS, Aragon FF, Padovani CR, Gerich JE.
Braz J Med Biol Res. 2003 Mar;36(3):301-8. Epub 2003 Mar 7.PMID: 12640493 [PubMed - indexed for MEDLINE]Related articlesFree article
Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes.
Meier JJ, Hücking K, Holst JJ, Deacon CF, Schmiegel WH, Nauck MA.
Diabetes. 2001 Nov;50(11):2497-504.PMID: 11679427 [PubMed - indexed for MEDLINE]Related articlesFree article
Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
Nauck M, Schmidt WE, Ebert R, Strietzel J, Cantor P, Hoffmann G, Creutzfeldt W.
J Clin Endocrinol Metab. 1989 Sep;69(3):654-62.PMID: 2668324 [PubMed - indexed for MEDLINE]Related articles
A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility.
Fritsche A, Stefan N, Hardt E, Schützenauer S, Häring H, Stumvoll M.
Eur J Clin Invest. 2000 May;30(5):411-8.PMID: 10809901 [PubMed - indexed for MEDLINE]Related articles
Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.
Schou JH, Pilgaard K, Vilsbøll T, Jensen CB, Deacon CF, Holst JJ, Vølund A, Madsbad S, Vaag AA.
J Clin Endocrinol Metab. 2005 Aug;90(8):4912-9. Epub 2005 May 17.PMID: 15899957 [PubMed - indexed for MEDLINE]Related articlesFree article
Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.
Groop L, Luzi L, Melander A, Groop PH, Ratheiser K, Simonson DC, DeFronzo RA.
Diabetes. 1987 Nov;36(11):1320-8.PMID: 3117609 [PubMed - indexed for MEDLINE]Related articles
Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.
Osei K, Gaillard T, Schuster D.
Obes Res. 2005 Jan;13(1):179-85.PMID: 15761178 [PubMed - indexed for MEDLINE]Related articles
The reduction in hepatic insulin clearance after oral glucose is not mediated by gastric inhibitory polypeptide (GIP).
Meier JJ, Gallwitz B, Siepmann N, Holst JJ, Deacon CF, Schmidt WE, Nauck MA.
Regul Pept. 2003 May 15;113(1-3):95-100.PMID: 12686467 [PubMed - indexed for MEDLINE]Related articles
Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients.
Osei K, Falko JM, O'Dorisio TM, Fields PG, Bossetti B.
J Clin Endocrinol Metab. 1986 Feb;62(2):325-30.PMID: 3510224 [PubMed - indexed for MEDLINE]Related articles
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
» See more...